Literature DB >> 12604789

The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity.

Rebecca L Landsberg1, Julia E Sero, Paul S Danielian, Tina L Yuan, Eunice Y Lee, Jacqueline A Lees.   

Abstract

The E2F and pocket protein families are known to play an important role in the regulation of both cellular proliferation and terminal differentiation. In this study, we have used compound E2F and pocket protein mutant mouse embryonic fibroblasts to dissect the role of these proteins in adipogenesis. This analysis shows that loss of E2F4 allows cells to undergo spontaneous differentiation. The ability of E2F4 to prevent adipogenesis seems to be quite distinct from the known properties of E2F. First, it can be separated from any change in either E2F-responsive gene expression or cell cycle regulation. Second, it is a specific property of E2F4, and not other E2Fs, and it occurs independently of E2F4's ability to interact with pocket proteins. In addition, E2F4 loss does not override the differentiation defect resulting from pRB loss even though it completely suppresses the proliferation defect of Rb(-/-) mouse embryonic fibroblasts. This finding definitively separates the known, positive role of pRB in adipogenesis from its cell cycle function and shows that this pocket protein is required to act downstream of E2F4 in the differentiation process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604789      PMCID: PMC151362          DOI: 10.1073/pnas.0138064100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

Authors:  S Altiok; M Xu; B M Spiegelman
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

Review 2.  The retinoblastoma gene family in differentiation and development.

Authors:  M M Lipinski; T Jacks
Journal:  Oncogene       Date:  1999-12-20       Impact factor: 9.867

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

Review 4.  Regulation of cell proliferation by the E2F transcription factors.

Authors:  K Helin
Journal:  Curr Opin Genet Dev       Date:  1998-02       Impact factor: 5.578

5.  E2F activity is regulated by cell cycle-dependent changes in subcellular localization.

Authors:  R Verona; K Moberg; S Estes; M Starz; J P Vernon; J A Lees
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB.

Authors:  G J Mulligan; J Wong; T Jacks
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting.

Authors:  G J Lindeman; L Dagnino; S Gaubatz; Y Xu; R T Bronson; H B Warren; D M Livingston
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

8.  Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation.

Authors:  V M Richon; R E Lyle; R E McGehee
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

9.  Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs.

Authors:  P L Chen; D J Riley; Y Chen; W H Lee
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

10.  Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene.

Authors:  J E LeCouter; B Kablar; P F Whyte; C Ying; M A Rudnicki
Journal:  Development       Date:  1998-12       Impact factor: 6.868

View more
  14 in total

Review 1.  Opposing roles of E2Fs in cell proliferation and death.

Authors:  Meredith E Crosby; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2004-12-21       Impact factor: 4.742

Review 2.  Retinoblastoma family genes.

Authors:  W Du; J Pogoriler
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

Review 3.  Role of cell cycle regulators in adipose tissue and whole body energy homeostasis.

Authors:  I C Lopez-Mejia; J Castillo-Armengol; S Lagarrigue; L Fajas
Journal:  Cell Mol Life Sci       Date:  2017-10-07       Impact factor: 9.261

4.  Disruption of calvarial ossification in E2f4 mutant embryos correlates with increased proliferation and progenitor cell populations.

Authors:  Emily S Miller; Seth D Berman; Tina L Yuan; Jacqueline A Lees
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 5.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

6.  E2f4 is required for normal development of the airway epithelium.

Authors:  Paul S Danielian; Carla F Bender Kim; Alicia M Caron; Eliza Vasile; Roderick T Bronson; Jacqueline A Lees
Journal:  Dev Biol       Date:  2007-03-03       Impact factor: 3.582

7.  DPL-1 DP, LIN-35 Rb and EFL-1 E2F act with the MCD-1 zinc-finger protein to promote programmed cell death in Caenorhabditis elegans.

Authors:  Peter W Reddien; Erik C Andersen; Michael C Huang; H Robert Horvitz
Journal:  Genetics       Date:  2007-01-21       Impact factor: 4.562

Review 8.  The rb pathway and cancer therapeutics.

Authors:  W Du; J S Searle
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

9.  Dysfunctional memory CD8+ T cells after priming in the absence of the cell cycle regulator E2F4.

Authors:  Simona Bancos; Qingyu Cao; William J Bowers; Ian Nicholas Crispe
Journal:  Cell Immunol       Date:  2009       Impact factor: 4.868

10.  Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis.

Authors:  Matthias Laudes; Constantinos Christodoulides; Ciaran Sewter; Justin J Rochford; Robert V Considine; Jaswinder K Sethi; Antonio Vidal-Puig; Stephen O'Rahilly
Journal:  J Biol Chem       Date:  2003-12-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.